Ireland
--:--IST
Latest
Clinical Trials in France / NCT06510972
Recruiting Not applicable

Non-inferiority of Continuing Oral Intake Versus Fasting in Patients With Acute Respiratory Failure

NCT06510972 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-02-05
Last updated
2026-02-18

Condition(s) studied

Respiratory InsufficiencyFastingDysphagiaSwallowing DisorderAspiration

Investigational drug(s) / intervention(s)

Oral intake continuation strategyFasting strategy

Oral intake continuation strategy: The patient will be allowed to ingest liquids or solid foods orally, of any type, at an unrestricted frequency and quantity, according to their tolerance.

Fasting strategy: The patient will not be able to ingest liquids or solid food.

Study summary

Fasting in intensive care is mainly studied in mechanically ventilated patients or those in the weaning phase. Recent research challenge the common assumption of fasting and suggests that continuing enteral nutrition before extubation may be beneficial. Fasting is also practiced before procedures (e.g., tracheostomy, endoscopy) or surgeries, based on anesthetic guidelines. Yet, no data address fasting in non-intubated ICU patients with acute respiratory failure, despite frequent caloric deficits and inadequate nutritional intake.

Aspiration risk often justifies fasting, but studies indicate that swallowing reflexes remain intact in patients receiving high-flow nasal oxygen or non-invasive ventilation. Moreover, although intubation carries a 2-5.9% aspiration risk, rapid sequence induction mitigates this, questioning the necessity of preventive fasting. Despite its prevalence, this practice lacks scientific validation and guideline support.

Patient discomfort is also significant. Hunger and thirst are major sources of distress, and evidence from anesthesiology suggests that allowing fluid intake pre-anesthesia reduces discomfort. Extrapolating these findings to ICU patients could improve well-being.

In conclusion, fasting in ICU patients may contribute to discomfort, dehydration, and malnutrition, while its protective benefits remain uncertain. We hypothesize that maintaining oral intake does not increase the risk of intubation or aspiration-related complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male or female ≥ 18 years old * Participant affiliated to a social security scheme * Express oral consent of the participant, or failing that of the trusted support person, or failing that of the next of kin * Patient hospitalised in an intensive care unit or in a continuous surveillance unit or in an intensive care unit for less than 24 hours. * Criteria for acute hypoxaemic respiratory failure defined as. * Respiratory rate \> 25 cpm or indifferent if SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) infection occurred ≥ 1 time since admission. * PaO2/FiO2 \< 200 mmHg or equivalent SpO2 (oxygen saturation)/FiO2 (fraction of inspired oxygen) i.e. \< 235 (measured under at least 10 L/min high concentration mask) Exclusion Criteria: * Patient with criteria for immediate intubation: * Persistent or worsening respiratory failure (respiratory rate \> 40/min, respiratory failure on physical examination, respiratory acidosis with pH (hydrogen potential ) \< 7.25, copious tracheal secretions, hypoxia with SpO2 \< 90% despite FiO2 \> 80% for more than 5 minutes without technical dysfunction). * Major haemodynamic failure (need for increasing vasopressor support with instability and hypoperfusion). * Neurological failure (Glasgow score \< 8). * Cardiac or respiratory arrest * Chronic lung disease: chronic obstructive pulmonary disease (GOLD grade 3 or 4: Global Initiative for Chronic Obstructive Lung Disease) or other chronic lung disease requiring long-term oxygen or ventilation (this does not include a patient undergoing continuous positive nocturnal pressure for sleep apnoea syndrome). * Contraindications to oral nutrition: known previous swallowing problems or inability to swallow, digestive sutures, admission for inhalation pneumonia, exclusive parenteral nutrition, etc. * Patients with a nasogastric or orogastric tube, a jejunostomy or a feeding ileostomy * Patient already on invasive mechanical ventilation on admission * Limitation of therapies including a decision not to intubate * Incapacitated adult (guardianship or curators) * Pregnant, parturient or breast-feeding women * Tracheostomised patient * Patient already included for the first time in this study

Primary outcome measure(s)

Trial sites (14)

FacilityCityRegionStatus
Intensive care, University Hospital, Blois Blois France Not Yet Recruiting
Intensive care, Hospital, Bourges Bourges France Recruiting
Intensive care, Hospital, Colombes Colombes France Recruiting
Intensive care, Hospital, Dreux Dreux France Recruiting
Intensive care, Hospital, La Roche sur Yon La Roche-sur-Yon France Recruiting
Intensive care, Hospital, Le MANS Le Mans France Recruiting
Intensive care, Hospital, Lille Lille France Recruiting
Intensive care, Hospital, Morlaix Morlaix France Recruiting
Intensive care, Hospital, Nantes Nantes France Recruiting
Intensive care, University Hospital, Orléans Orléans France Recruiting
Intensive care, Hospital, poitiers Poitiers France Recruiting
Intensive care, Hospital, Saint Brieuc Saint-Brieuc France Recruiting
Intensive care, Hospital, Saint-Nazaire Saint-Nazaire France Recruiting
Intensive care, University Hospital, Tours Tours France Recruiting

More University Hospital, Tours trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06510972 on ClinicalTrials.gov ↗ ← All trials in France